These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36181235)

  • 1. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
    Fan HQ; Wang YC; He W; Zhou HW; Yang T
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
    Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
    Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
    Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
    Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
    Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNRHR-related central hypogonadism with spontaneous recovery - case report.
    Šmigoc Schweiger D; Davidović Povše M; Trebušak Podkrajšek K; Battelino T; Avbelj Stefanija M
    Ital J Pediatr; 2022 Nov; 48(1):184. PubMed ID: 36371229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
    Chen Y; Sun T; Niu Y; Wang D; Xiong Z; Li C; Liu K; Qiu Y; Sun Y; Gong J; Wang T; Wang S; Xu H; Liu J
    J Sex Med; 2020 Apr; 17(4):645-657. PubMed ID: 32171629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect and safety of pulsatile GnRH therapy for male congenital hypogonadotropic hypogonadism].
    Niu YH; Xu H; Chen YW; Lan RZ; Wang T; Wang SG; Liu JH
    Zhonghua Nan Ke Xue; 2024 May; 30(5):404-409. PubMed ID: 39210488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in anterior pituitary response in patients with idiopathic hypothalamic hypogonadism caused by pulsatile GnRH therapy and testosterone replacement.
    Schopohl J; Mojto J; Losa M; Mehltretter G; Müller OA; von Werder K
    Exp Clin Endocrinol Diabetes; 1995; 103(3):184-90. PubMed ID: 7584521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study.
    Hao M; Mao JF; Guan QB; Tian L; Han H; Lei HE; Zheng DM; Tian ZH; Nie M; Wang X; Yu BQ; Gao YJ; Wu XY
    Ann Transl Med; 2021 Jun; 9(12):962. PubMed ID: 34277762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
    Naharci MI; Pinar M; Bolu E; Olgun A
    Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty.
    Mosbah H; Bouvattier C; Maione L; Trabado S; De Filippo G; Cartes A; Donzeau A; Chanson P; Brailly-Tabard S; Dwyer AA; Coutant R; Young J
    Hum Reprod; 2020 Oct; 35(10):2312-2322. PubMed ID: 32862222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kisspeptin-54 Accurately Identifies Hypothalamic Gonadotropin-Releasing Hormone Neuronal Dysfunction in Men with Congenital Hypogonadotropic Hypogonadism.
    Abbara A; Eng PC; Phylactou M; Clarke SA; Mills E; Chia G; Yang L; Izzi-Engbeaya C; Smith N; Jayasena CN; Comninos AN; Anand-Ivell R; Rademaker J; Xu C; Quinton R; Pitteloud N; Dhillo WS
    Neuroendocrinology; 2021; 111(12):1176-1186. PubMed ID: 33227799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of idiopathic hypogonadotropic hypogonadism.
    Raivio T; Falardeau J; Dwyer A; Quinton R; Hayes FJ; Hughes VA; Cole LW; Pearce SH; Lee H; Boepple P; Crowley WF; Pitteloud N
    N Engl J Med; 2007 Aug; 357(9):863-73. PubMed ID: 17761590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
    Pitteloud N; Dwyer A
    Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
    Delemarre-van de Waal HA
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.